Thunes' proprietary Network is now the only real-time alternative to the legacy system for sending payments to bank accounts in Taiwan.
LONDON and SINGAPORE,Feb. 20,2025 --Thunes,the Smart Superhighway to move money around the world,today announced the expansion of its Direct Global Network into Taiwan. This expansion brings Thunes' Pay-to-Banks payment capabilities to Taiwan,enhancing the company's cross-border payment services in one of Asia's most technologically advanced and financially dynamic markets.
With this expansion,Members of Thunes' Direct Global Network can now provide their customers with real-time payout services into Taiwan in both New Taiwan Dollars (TWD) and United States Dollars (USD). This solution supports all major banks in Taiwan and enables real-time payments to both individual and business bank accounts.
Taiwan is a key hub for international trade and finance,with a strong demand for efficient cross-border payments. According to recent data,in January 2025,Taiwan's total exports amounted to $38.7 billion,representing a 4.4% increase compared to January 2024. The Taiwan Institute of Economic Research's (TIER) forecast for Taiwan's 2025 gross domestic product (GDP) growth is 3.42%,citing positive factors including increasing investments,solid private consumption and stronger exports. As such,the country's money influx market continues to grow as Taiwan remains a key trade partner for economies around the world.
Floris de Kort,CEO at Thunes,said:"Expanding Thunes' proprietary Direct Global Network with our new payments corridor into Taiwan provides our Members with greater speed,control,visibility,protection,and cost efficiencies for real-time cross-border payments in one of Asia's most vibrant financial markets. This expansion underscores our commitment to global reach and industry-leading Quality of Service through direct connections,enabling our Members to seamlessly process payments worldwide,with the highest transaction success rates."
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map